Brunner K T, MacDonald H R, Cerottini J C
J Exp Med. 1981 Aug 1;154(2):362-73. doi: 10.1084/jem.154.2.362.
A limiting dilution mixed leukocyte-tumor cell microculture system was used to quantitate cytolytic T lymphocytes and their precursors (CTL-P), which infiltrate tumors induced by injection of Moloney sarcoma-leukemia virus (MSV-MoLV) complex into C57BL/6 mice. Leukocyte populations obtained from tumors collected on day 10 after virus injection were found to contain significantly higher frequencies of operationally defined (tumor-specific) CTL-P than either peripheral blood leukocytes (PBL) or spleen cells from the same animals. When these frequencies were normalized according to the content of Lyt-2+ T cells in each tissue, average CTL-P frequencies were found to be 1/9 in tumor-infiltrating cells vs. 1/41 in PBL. These results directly demonstrate selective accumulation of CTL-P in the tumor mass. A number of clonal isolates obtained from tumor-infiltrating leukocyte populations were expanded and studied for cytolytic activity and specificity. Of 11 isolates, 10 were found to have high cytolytic activity, leading to 50% lysis of the syngeneic MoLV-derived tumor target cells in 3.5 h at lymphocyte:target cell ratios ranging from 0.5:1 to 3.2:1. Furthermore, five randomly selected clones showed H-2 restriction by their selective lytic activity against MoLV-derived syngeneic MBL-2 target cells and their lack of activity against either MoLV-derived allogeneic (LSTRA) tumor cells or against syngeneic (EL4) or allogeneic (P815) target cells unrelated to MoLV.
采用极限稀释混合白细胞-肿瘤细胞微量培养系统对细胞溶解性T淋巴细胞及其前体(CTL-P)进行定量分析,这些细胞浸润于将莫洛尼肉瘤-白血病病毒(MSV-MoLV)复合物注射到C57BL/6小鼠体内所诱导产生的肿瘤中。发现在病毒注射后第10天收集的肿瘤中获得的白细胞群体,与来自相同动物的外周血白细胞(PBL)或脾细胞相比,其操作定义的(肿瘤特异性)CTL-P频率显著更高。当根据每个组织中Lyt-2 + T细胞的含量对这些频率进行标准化时,发现肿瘤浸润细胞中的平均CTL-P频率为1/9,而PBL中的为1/41。这些结果直接证明了CTL-P在肿瘤块中的选择性积累。从肿瘤浸润白细胞群体中获得的许多克隆分离株被扩增,并研究其细胞溶解活性和特异性。在11个分离株中,发现10个具有高细胞溶解活性,在淋巴细胞与靶细胞比例为0.5:1至3.2:1的情况下,3.5小时内可导致同基因MoLV衍生的肿瘤靶细胞50%溶解。此外,五个随机选择的克隆通过其对MoLV衍生的同基因MBL-2靶细胞的选择性裂解活性以及对MoLV衍生的异基因(LSTRA)肿瘤细胞或与MoLV无关的同基因(EL4)或异基因(P815)靶细胞缺乏活性,表现出H-2限制性。